Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma

Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma

Xin-Wei Guo,1,* Yang-Chen Liu,2,* Fei Gao,2,* Sheng-Jun Ji,3 Ju-Ying Zhou,1 Lei Ji,1 Shao-Bing Zhou2 1Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; 2Department of Radiation Oncology, Affiliated Taixing People&...

Full description

Bibliographic Details
Main Authors:	Guo XW, Liu YC, Gao F, Ji SJ, Zhou JY, Ji L, Zhou SB
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-08-01
Series:	Cancer Management and Research
Subjects:	Esophageal squamous cell carcinoma Surgery Hematological markers Nutritional risk screening Prognosis
Online Access:	https://www.dovepress.com/pretreatment-nrs-2002-scores-combined-with-hematologic-inflammation-ma-peer-reviewed-article-CMAR

Similar Items

Influential factors on radiotherapy efficacy and prognosis in patients with secondary lymph node metastasis after esophagectomy of thoracic esophageal squamous cell carcinoma
by: Zhou SB, et al.
Published: (2018-02-01)

Increasing Radiation Dose to the Thoracic Marrow Is Associated With Acute Hematologic Toxicities in Patients Receiving Chemoradiation for Esophageal Cancer
by: Denise Fabian, et al.
Published: (2019-03-01)

Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients
by: Hirotake Saito, et al.
Published: (2018-02-01)

A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
by: Yu Yang, et al.
Published: (2024-04-01)

Value of Nomogram Incorporated Preoperative Tumor Volume and the Number of Postoperative Pathologically Lymph Node Metastasis Regions on Predicting the Prognosis of Thoracic Esophageal Squamous Cell Carcinoma
by: Guo XW, et al.
Published: (2021-06-01)

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2023-04-01)

CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
by: Jinfeng Cui, et al.
Published: (2024-03-01)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
by: Zongdan Jiang, et al.
Published: (2021-11-01)

Quality of life after esophageal resection
by: Svetanoff WJ, et al.
Published: (2018-04-01)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
by: Takeshi Kawakami, et al.
Published: (2018-05-01)

Thoracoscopic resection of thoracic esophageal duplication cyst containing ectopic pancreatic tissue in adult
by: Morimura Keiichirou, et al.
Published: (2011-09-01)

Endoscopic resections for superficial esophageal squamous cell epithelial neoplasia: focus on histological discrepancies between biopsy and resected specimens
by: Lang Yang, et al.
Published: (2021-03-01)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
by: Akiyuki Wakita, et al.
Published: (2023-11-01)

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma
by: Wenjie Ni, et al.
Published: (2020-02-01)

Mediastinoscopy-assisted esophagectomy for T2 middle and lower thoracic esophageal squamous cell carcinoma patients
by: Jun Wang, et al.
Published: (2018-03-01)

Treatment of Esophago–Airway Fistula after Esophageal Resection
by: Janusz Włodarczyk, et al.
Published: (2023-12-01)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
by: Chengzhi Ding, et al.
Published: (2023-12-01)

Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
by: Liang Yi, et al.
Published: (2012-05-01)

Risk factors for metachronous esophageal squamous cell carcinoma after endoscopic or surgical resection of esophageal carcinoma: a systematic review and meta-analysis
by: Jie Du, et al.
Published: (2023-09-01)

Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
by: Francesco Cavallin, et al.
Published: (2017-05-01)

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
by: Zhen Wang, et al.
Published: (2022-06-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
by: Xianfeng Li, et al.
Published: (2023-01-01)

Global time trends in the incidence of esophageal squamous cell carcinoma
by: Wang QL, et al.
Published: (2018-06-01)

Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities
by: Leif Hendrik Dröge, et al.
Published: (2021-04-01)

Right Compared With Left Thoracic Approach Esophagectomy for Patients With Middle Esophageal Squamous Cell Carcinoma
by: Yan Zheng, et al.
Published: (2020-10-01)

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma
by: Tatsuya Suwa, et al.
Published: (2021-09-01)

Esophageal lung resection and prosthesis placement in a preterm neonate
by: Lalit Parida, et al.
Published: (2015-01-01)

Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
by: Gang Ji, et al.
Published: (2024-04-01)

Lymph node metastatic patterns and its clinical significance for thoracic superficial esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2020-09-01)

Hematology and Dermatology /
by: Asher, Marshall, author 648334, et al.
Published: (2012)

Management of esophageal perforation following endoscopic submucosal resection of superficial esophageal cancer
by: Anna Śliwa, et al.
Published: (2021-07-01)

Liver resection for hepatocellular carcinoma in patients with hematological malignancies
by: Hui-Chen Lin, et al.
Published: (2017-11-01)

Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China
by: Erica Conway, et al.
Published: (2023-11-01)

Esophageal squamous cell carcinoma presenting as a submucosal tumor
by: Lin Yang, et al.
Published: (2023-08-01)

Evaluation of non-invasive marker of esophageal varices in cirrhosis of liver
by: Pardeep Kumar, et al.
Published: (2020-01-01)

Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions
by: Zhihao Chen, et al.
Published: (2021-11-01)

Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma
by: Haiyang Hu, et al.
Published: (2022-08-01)

Role of Log Odds of Positive Lymph Nodes in Predicting Long-term Prognosis of Patients with Thoracic Esophageal Squamous Cell Carcinoma
by: GAO Hongmei, et al.
Published: (2020-03-01)

Giant esophageal liposarcoma with squamous cell carcinoma resected via the cervical approach: a case report
by: Tomohiro Okura, et al.
Published: (2022-06-01)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
by: Rutao Li, et al.
Published: (2022-09-01)